Atlas Trials

Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency

Clinical trial NCT06756620 · COMPLETED

Trial details

NCT number
NCT06756620
Sponsor
Ozge Bayrak Demirel
Status
COMPLETED
Study type
OBSERVATIONAL
Cytochrome P450 Oxidoreductase DeficiencyHypertensionEndothelial DysfunctionCongenital Adrenal Hyperplasia
Start date
2024-12-24
Primary completion
2025-08-12
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.